Industry Symposium: Breaking New Ground in Rheumatology: We Haven’t Come This Far, to Only Come This Far

Sponsored by

Dr Jeremy Sokolove, United States
Prof John Isaacs, United Kingdom
Prof Ranjeny Thomas, Australia

Prof Ranjeny Thomas, Australia

Over the past thirty years Rheumatology has undergone a paradigm shift in the approach to treatment and management of rheumatologic conditions. Basic scientific and clinical discoveries have informed our understanding of the pathologic and molecular mechanisms that contribute to these diseases. This, together with the application of rapid advances in technologies, has enabled the development of targeted therapeutic agents and management strategies that have transformed patient care. However, even now in the 21st Century, we still have much to learn and significant unmet patient needs remain to be addressed in the field of rheumatology.
In an interactive and engaging symposium, our distinguished speakers, will take you through:

  • the challenges and pitfalls of target identification, drug development & translational science to address the unmet needs in rheumatology
  • where are we now and what does the future hold in utilising genomics and biomarkers to inform personalised medicine in Rheumatology
  • Australia’s contribution to the advances in rheumatology

Prof Ranjeny Thomas


Tuesday 9 April 2019
Time Topic Speaker
1755 – 1800 Welcome & Introduction Prof Ranjeny Thomas
1800 – 1815 Challenges of drug discovery & translational science Dr Jeremy Sokolove
1815 – 1835 Genomics, biomarkers and personalised medicine in rheumatology Prof John Isaacs
1835 – 1845 The Australian contribution to the future of rheumatology Prof Ranjeny Thomas
1845 – 1855 Panel Q&A All
1855 Close